Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

FDA Approves Potiga™ (ezogabine)

By Pharmaceutical Processing | June 13, 2011

 

Valeant Pharmaceuticals International, Inc. and
GlaxoSmithKline announced today that the FDA has approved Potiga™ (ezogabine)
Tablets, a potassium channel opener, as adjunctive treatment of partial-onset
seizures in patients aged 18 years and older.

“We are so pleased to reach such an important milestone
with the U.S.
approval of Potiga by the FDA,” stated Susan Hall, PhD, head of research
and development at Valeant. “We believe this product will play a needed
role in the management of partial onset seizures in appropriate patients who
are uncontrolled on their current medications.”

FDA has recommended that ezogabine be scheduled as a
controlled substance under the Controlled Substances Act (CSA). Final
classification is still under review by the Federal Drug Enforcement
Administration (DEA) and ezogabine will not be available until this process is
complete.

Ezogabine is expected to be available in U.S. pharmacies
by the end of the year.

 

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE